Transcranial Direct Current Stimulation for Parkinson's Disease
(tDCS Trial)
JK
Overseen ByJessica Keller, B.S.
Age: Any Age
Sex: Any
Trial Phase: Academic
Sponsor: Sanford Health
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Trial Summary
What is the purpose of this trial?
The investigators hypothesize that multi-session anodal tDCS (atDCS) of the left dorsolateral prefrontal cortex (LDLPFC) will induce long-lasting effects in improving motor function and reducing motor fatigue and fatigability in PD patients.
Research Team
JL
Jau-Shin Lou, MD
Principal Investigator
Sanford Health
Eligibility Criteria
This trial is for individuals with Parkinson's Disease who experience motor function difficulties and fatigue. Participants must be eligible based on specific criteria set by the researchers, which are not detailed here.Inclusion Criteria
Must be able to consent
I have Parkinson's with symptoms like tremor or stiffness.
Exclusion Criteria
I have been diagnosed with congestive heart failure.
Patients with dementia (MOCA < 21)
I am receiving or have received DBS for Parkinson's disease.
See 4 more
Timeline
Screening
Participants are screened for eligibility to participate in the trial
1-2 weeks
Treatment
Participants receive 2mA of anodal transcranial direct current stimulation (tDCS) for 20 minutes daily for 5 consecutive days
1 week
5 visits (in-person)
Follow-up
Participants are monitored for safety and effectiveness after treatment
2 weeks
3 visits (in-person)
Treatment Details
Interventions
- Transcranial Direct Current Stimulation
Trial Overview The study tests if a non-invasive brain stimulation technique called anodal transcranial direct current stimulation (atDCS) can improve movement and reduce tiredness in Parkinson's patients compared to no treatment.
Participant Groups
2Treatment groups
Experimental Treatment
Placebo Group
Group I: Experimental GroupExperimental Treatment1 Intervention
The experimental group will receive 2mA of anodal transcranial direct current stimulation (tDCS) for 20 minutes daily for 5 consecutive days.
Group II: Sham GroupPlacebo Group1 Intervention
The sham group will be connected to the anodal transcranial direct current stimulation device daily for 5 days. During the 20 minute sessions, the participant will only receive stimulation for a 30-second ramp up period, at which point the stimulation will be discontinued for the remainder of the time.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Sanford Health
Lead Sponsor
Trials
53
Recruited
2,067,000+
Other People Viewed
By Subject
By Trial
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.